thumbnail image
HomeAbout UsDeal TeamPortfolioNewsContact Us
HomeAbout UsDeal TeamPortfolioNewsContact Us
中文
HomeAbout UsDeal TeamPortfolioNewsContact Us
HomeAbout UsDeal TeamPortfolioNewsContact Us
HomeAbout UsDeal TeamPortfolioNewsContact Us
中文
  • Home
  • About Us
  • Deal Team
  • Portfolio
  • News
  • Contact Us
    •  

       

       

      STEPHEN LIN

      Partner

    • Stephen Lin, is a Partner with Lilly Asia Ventures (LAV). Prior to joining LAV, he most recently worked as BD at GlaxoSmithKline (Great China), covering M&A and product licensing. Prior to that, he managed the marketing of a core product at Merck Serono (China). In Sanjiu Medical & Pharmaceutical, he set up and headed the Strategic Development Department. Stephen holds Master of Science in Medicinal Chemistry and Bachelor in Pharmaceutical Chemistry, both from China Pharmaceutical University, and an M.B.A. degree from China Europe International Business School. He is also a Licensed Pharmacist in China.

    Company

     

    Shanghai

    Room2909-14, 168 Hubin Road, Huangpu District, Shanghai, China.

     

     

    Hong Kong

    Unit 902-904, Two ChinaChem Central, 26 Des Voeux Road Central, Hong Kong

     

     

    US

    2730 Sand Hill Road, Suite 130, Menlo Park, CA

    copyright © 2018 Lilly Asia Ventures all rights reserved.

    沪ICP备12003647号

    沪公网安备 31010102005458号

      All Posts
      ×
      LillyAsiaVentures
      Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
      http://user-assets.sxlcdn.com/images/315509/FnksTvTDur7jpExbqYminmtjWgoM.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/format/png
      Cookie Use
      We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
      Learn More